Treatment settings and metabolic monitoring for people experiencing first-episode psychosis

Catherine Batscha, Mark E. Schneiderhan, Yachana Kataria, Cherise Rosen, Robert W. Marvin

Research output: Contribution to journalArticlepeer-review

8 Scopus citations


Monitoring for metabolic sequelae of antipsychotic medications is inconsistent in clinical settings. In this study, frequency of such monitoring in 40 individuals experiencing a first episode of psychosis was analyzed according to the setting in which they received treatment (i.e., inpatient unit, outpatient clinic, or metabolic screening clinic). The traditional outpatient clinic was the least likely of the three settings to monitor blood glucose, blood pressure, weight, and waist circumference. In any setting, blood lipids were measured in only 2 of the 40 patients. Reasons for these findings and recommendations for reducing barriers to screening are presented.

Original languageEnglish (US)
Pages (from-to)44-49
Number of pages6
JournalJournal of psychosocial nursing and mental health services
Issue number9
StatePublished - Sep 2010


Dive into the research topics of 'Treatment settings and metabolic monitoring for people experiencing first-episode psychosis'. Together they form a unique fingerprint.

Cite this